prednisone has been researched along with Autoimmune Thrombocytopenia in 201 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Her major chronic illness was immune thrombocytopenic purpura (ITP) for which she had been treated with prednisone therapy for the past 15 years." | 7.80 | From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia. ( Hill, LJ; Tung, EE, 2014) |
| "This report describes a case of methemoglobinemia in association with dapsone therapy." | 7.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
| "Antinuclear antibody (ANA)-positive immune thrombocytopenia (ITP) patients have an unsatisfactory prognosis due to the more severe conditions of these patients and poor response to first-line glucocorticoids (GCs)." | 5.91 | Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study. ( Chen, X; Dong, Z; Ma, L; Su, J; Wang, Q; Xiao, P; Xu, M, 2023) |
| "Prednisone (1 mg/kg/d) was started and fever disappeared on the same day." | 5.43 | Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids. ( Dai, YQ; Liu, ZH; Shen, H; Zhang, Y; Zhu, J, 2016) |
| "The immune thrombocytopenic purpura (ITP) is an immunological disease associated with pregnancy; it is difficult to control when there is not an adequate response to the treatment mainly with prednisone (refractory)." | 4.79 | [Management of refractory autoimmune thrombocytopenic purpura during pregnancy, Review of the literature and report of three cases]. ( García Alonso López, A; Izquierdo Puente, JC; Jiménez Solís, G; López Rangel, JA; Yáñez Maldonado, E, 1997) |
| " We describ the case of a young soldier who, after returning from Central Africa, presented a fever associated with petechial purpura and gingivorrhagia, hemogram showed deep thrombocytopenia and macrocytic normochrome anemia, thick peripheral blood smears confirmed the diagnosis of Plasmodium falciparum malaria, the patient was treated with quinine, but deep thrombocytopenia and hemorrhagic manifestations persisted, the patient then underwent corticosteroid therapy, with favorable evolution and progressive normalization of platelets." | 3.85 | Immune thrombocytopenia associated with malaria: a case report. ( Fatihi, J; Miloudi, M; Sbaai, M, 2017) |
| " Her major chronic illness was immune thrombocytopenic purpura (ITP) for which she had been treated with prednisone therapy for the past 15 years." | 3.80 | From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia. ( Hill, LJ; Tung, EE, 2014) |
| " She was treated early in pregnancy with high-dose oral prednisone and weekly intravenous immunoglobulin (IVIG) alternating with anti-D immune globulin, but laparoscopic splenectomy was indicated at 20 weeks' gestation because of thrombocytopenia." | 3.73 | Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. ( Griffiths, J; Shapiro, AM; Sia, W; Tataryn, I; Turner, AR, 2005) |
| "This report describes a case of methemoglobinemia in association with dapsone therapy." | 3.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
| "This randomized trial was performed to investigate the efficacy of low-dose rituximab in combination with glucocorticoids for treatment of patients with immune thrombocytopenia (ITP)." | 2.76 | Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. ( Cao, J; He, X; Li, Z; Lu, G; Mou, W; Pan, X; Xu, K, 2011) |
| "The treatment of chronic idiopathic thrombocytopenic purpura (ITP) is difficult in those unresponsive to corticosteroids and/or splenectomy." | 2.71 | Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura. ( Hou, M; Ji, X; Peng, J; Qin, P; Shi, Y; Wang, X; Zhang, C; Zhang, M; Zhao, C, 2003) |
| "Oral prednisone alone was used in 50 of the 59 patients (mean initial dose 1 mg/kg body weight/day)." | 2.70 | Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. ( Arnal, C; Bierling, P; Godeau, B; Hachulla, E; Léone, J; Papo, T; Piette, JC; Roudot-Thoraval, F; Schaeffer, A; Taillan, B, 2002) |
| "Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies." | 2.70 | Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. ( Bassompierre, F; Bierling, P; Chevret, S; Chèze, S; Fain, O; Godeau, B; Grange, MJ; Hulin, C; Lefrère, F; Legouffe, E; Varet, B; Zini, JM, 2002) |
| "To explore the clinical effect of recombinant roasted licorice decoction (RRLD) combined with low-dose glucocorticoids (GC) in treating idiopathic thrombocytopenic purpura (ITP)." | 2.70 | [Clinical study on effect of recombinant roasted licorice decoction combined with low-dose glucocorticoids in treating idiopathic thrombocytopenic purpura]. ( Hu, J; Liu, YQ; Luo, YG, 2001) |
| "Seven patients (one with cold agglutinin disease, two with warm antibody autoimmune hemolytic anemia, four with chronic idiopathic thrombocytopenic purpura) previously refractory to conventional treatments were treated with weekly infusions of rituximab, 375 mg/m2, for 4 weeks." | 2.70 | B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. ( Baccarani, M; de Vita, S; Fanin, R; Iacona, I; Masolini, P; Patriarca, F; Prosdocimo, S; Regazzi, M; Russo, D; Sperotto, A; Zaja, F, 2002) |
| " We know that long-term use of corticosteroids can lead to significant morbidities; there is no consensus regarding the appropriate timing or indications for splenectomy." | 2.69 | Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. ( George, JN, 2000) |
| "The article studied 61 patients with idiopathic thrombocytopenic purpura, they were classified and treated with Chinese herbal medicine Zhinu (ZN) -I, -II, in comparison with 30 cases of patients treated with prednisone." | 2.68 | [Clinical study of zhinu-I,-II in treating 61 patients with idiopathic thrombocytopenic purpura]. ( Hong, F; Yang, YQ; Zeng, FC, 1996) |
| "A total of 121 patients with fewer than 50 x 10(9) platelets per liter received an initial treatment with prednisone (PDN) at a dosage of 1 mg/kg of body weight for 1 month." | 2.68 | Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. ( Adomo, G; Amadori, S; Cecconi, M; Masi, M; Oliva, F; Perrotti, AP; Sciarra, A; Scimò, MT; Stasi, R; Stipa, E, 1995) |
| " The present study was designed to evaluate the ability of specific inspiratory muscle training (SIMT) to prevent the effects of a therapeutic dosage of corticosteroids on inspiratory muscle function in patients receiving the drug for diseases other than pulmonary, with no underlying respiratory or muscular disease." | 2.68 | Inspiratory muscle training during treatment with corticosteroids in humans. ( Azgad, Y; Weiner, M; Weiner, P, 1995) |
| "Although acute inflammatory polyneuropathy (AIP) and immune thrombocytopenic purpura (ITP) are both believed to be immune-mediated disorders, only a few cases have been reported in which these two diseases co-existed." | 2.43 | Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura. ( Akiyama, N; Kamata, T; Kanda, T; Kuwana, M; Sato, N, 2005) |
| "Chronic idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction due to an antiplatelet autoantibody, usually of the IgG class, which coats autologue platelets and leads to their elimination by the reticuloendothelial system (RES)." | 2.40 | [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects]. ( Böcher, A; Hagmann, FG; Kreiter, H, 1998) |
| "Among them anemia, leukocytosis, and thrombocytosis are commonly seen." | 2.40 | Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? ( Ammirati, M; Gruenstein, S; Kim, P; Korelitz, BI; Lipsey, L; Schwarz, S; Wisch, N; Zlatanic, J, 1997) |
| "We report a case of autoimmune thrombocytopenic purpura associated with hyperthyroidism in which the patient's thrombocytopenia and thyrotoxicosis resolved concomitantly." | 2.40 | Autoimmune thrombocytopenic purpura associated with hyperthyroidism in a single individual. ( Aggarwal, A; Doolittle, G, 1997) |
| "Immune thrombocytopenic purpura is a relatively common disease that occurs in both pediatric and adult populations." | 2.38 | Acute and chronic immune thrombocytopenic purpura. Disorders that differ in more than duration. ( Kirchner, JT, 1992) |
| "Prednisone was the most commonly used first-line therapy (75." | 1.91 | Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods-One-Center Experience. ( Lebowa, W; Sacha, T; Zdziarska, J, 2023) |
| "Antinuclear antibody (ANA)-positive immune thrombocytopenia (ITP) patients have an unsatisfactory prognosis due to the more severe conditions of these patients and poor response to first-line glucocorticoids (GCs)." | 1.91 | Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study. ( Chen, X; Dong, Z; Ma, L; Su, J; Wang, Q; Xiao, P; Xu, M, 2023) |
| "Women with immune thrombocytopenia (ITP) are at increased risk of developing PPH." | 1.62 | Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study. ( Chang, YJ; Chen, Q; Feng, R; Hu, JD; Huang, QS; Huang, RW; Huang, XJ; Jiang, H; Jiang, M; Jiang, Q; Jiang, ZX; Liang, MY; Liu, FQ; Liu, H; Liu, HX; Liu, X; Liu, Y; Lu, J; Qian, SX; Qu, QY; Shen, XL; Su, Y; Sun, XY; Wang, JL; Wang, JW; Xiao, Z; Xu, LP; Yang, LH; Yang, TH; Yao, HX; Yin, CH; Zhan, SY; Zhang, GC; Zhang, HY; Zhang, JY; Zhang, L; Zhang, XH; Zhu, XL, 2021) |
| "A proportion of patients with immune thrombocytopenic purpura are refractory to multiple therapies including thrombopoietin-receptor agonists (TPO-RA)." | 1.51 | Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series. ( Gernsheimer, TB; Poston, JN, 2019) |
| "Acquired hemophilia A (AHA) is a rare bleeding disease caused by autoantibodies against factor VIII (FVIII)." | 1.48 | Successful treatment of acquired hemophilia A associated with immune thrombocytopenia and joint hemarthrosis: A case report and literature review. ( Wei, F, 2018) |
| "The incidence of pregnancy induced hypertension in GC therapy group was significantly higher than controls (22." | 1.48 | Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy: Response rate and complication. ( Dou, S; Liang, MY; Wang, JL; Xu, X; Zhang, XH, 2018) |
| "Here, we report a case of severe immune thrombocytopenia that occurred after orthotopic liver transplant." | 1.48 | Successful Treatment of Severe Immune Thrombocytopenia After Orthotopic Liver Transplant. ( Gao, W; Song, JL; Yan, LN; Yang, J; Yang, JY, 2018) |
| "Childhood immune thrombocytopenia (ITP) has been associated with low bleeding rates and a high frequency of spontaneous remission." | 1.46 | Using a standardised protocol was effective in reducing hospitalisation and treatment use in children with newly diagnosed immune thrombocytopenia. ( Chartrand, C; Di Liddo, L; Labrosse, R; Nguyen, UP; Pastore, Y; Vincent, M, 2017) |
| "Prednisone (1 mg/kg/d) was started and fever disappeared on the same day." | 1.43 | Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids. ( Dai, YQ; Liu, ZH; Shen, H; Zhang, Y; Zhu, J, 2016) |
| "Corticosteroid (CS)-related infection risk in immune thrombocytopenia (ITP) is unknown." | 1.42 | Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study. ( Lapeyre-Mestre, M; Moulis, G; Palmaro, A; Sailler, L, 2015) |
| "Autoimmune thrombocytopenic purpura is an immunological disorder characterized by increased platelet destruction due to presence of anti-platelet autoantibodies." | 1.40 | The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. ( Lebano, R; Masarone, M; Persico, M; Romano, M; Rosato, V, 2014) |
| "Pregnant women with Idiopathic thrombocytopenic purpura (ITP) can deliver neonates with severe thrombocytopenia." | 1.39 | Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. ( Brand, A; Lopriore, E; van der Lugt, NM; van Kampen, A; Walther, FJ, 2013) |
| "Interstitial lung disease is a rare but recognised complication of rituximab but has been rarely reported in the setting of ITP." | 1.38 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. ( Berkahn, L; Child, N; O'Carroll, M, 2012) |
| "The association of sarcoidosis and immune thrombocytopenia (ITP) has rarely been investigated." | 1.37 | Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients. ( Affo, L; Boutboul, D; Chiche, L; Dion, G; Ducroix, JP; Godeau, B; Khellaf, M; Le Guenno, G; Lidove, O; Mahévas, M; Michel, M; Morin, AS; Pacheco, Y; Papo, T; Péronne, V; Schleinitz, N; Uzunhan, Y; Valeyre, D, 2011) |
| "A patient was diagnosed with autoimmune thrombocytopenia and concurrent diffuse large B-cell lymphoma (DLBCL)." | 1.37 | Diffuse large B-cell lymphoma complicated with autoimmune thrombocytopenia. ( Ikeda, T; Sato, K; Uchiyama, M, 2011) |
| "We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive." | 1.36 | Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. ( Allegra, A; Alonci, A; D'Angelo, A; Granata, A; Musolino, C; Penna, G, 2010) |
| "Idiopathic thrombocytopenic purpura is an autoimmune disorder characterized by a low platelet count." | 1.35 | [Anesthetic management in a pregnant woman suffering from idiopathic thrombocytopenic purpura]. ( Borras, R; Cambray, C; Jamart, V; Mailan, J; Raynard Ortiz, M, 2009) |
| "Some infants with acute immune thrombocytopenic purpura (ITP) do not respond to first-line therapy, and currently there is no consensus on therapy for these refractory cases." | 1.35 | Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab. ( Hatakeyama, N; Hori, T; Iesato, K; Inazawa, N; Suzuki, N; Tsutsumi, H; Yamamoto, M, 2009) |
| "Prednisone treatment did not significantly modify the function and expression of MDR1 in T and NK cells of ITP patients." | 1.35 | Multidrug resistance-1 in T lymphocytes and natural killer cells of adults with idiopathic thrombocytopenic purpura: effect of prednisone treatment. ( Crespo-Solís, E; Graue, G; López-Karpovitch, X; Piedras, J, 2008) |
| "Serositis was resolved in both cases." | 1.34 | [Rituximab for treatment of patients with systemic autoimmune diseases]. ( Castillo Palma, MJ; Colorado Bonilla, R; García Hernández, FJ; Garrido Rasco, R; González León, R; Ocaña Medina, C; Sánchez Román, J, 2007) |
| "Recurrent immune thrombocytopenic purpura (ITP) is defined as the recurrence of ITP after at least 3 months of remission sustained without treatment." | 1.33 | Recurrent immune thrombocytopenic purpura in children. ( Jayabose, S; Levendoglu-Tugal, O; Ozkaynak, MF; Sandoval, C, 2006) |
| "A predisposition to developing immune thrombocytopenia (ITP) has not been reported in survivors of childhood cancer." | 1.33 | Immune thrombocytopenia following successful treatment of cancer in children. ( Barnes, C; Blanchette, V; Canning, P; Greenberg, M; Price, V, 2006) |
| "Idiopathic or immune thrombocytopenia purpura (ITP) is a common hematologic disease in children." | 1.32 | Outcome of children with idiopathic thrombocytopenic purpura, based on original material. ( Kattski, K; Kowalczyk, JR; Nurzyńska-Flak, J; Zawitkowska-Klaczyńska, J, 2004) |
| "Patients with chronic immune thrombocytopenic purpura (ITP) who are unresponsive to corticosteroids require splenectomy, but if this fails, treatment is difficult." | 1.31 | Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy. ( Kappers-Klunne, MC; van't Veer, MB, 2001) |
| "Although thrombotic thrombocytopenic purpura may, rarely, be associated with systemic lupus erythematosus and other autoimmune diseases, to our knowledge, the syndrome has never been described in association with autoimmune hepatitis." | 1.31 | Thrombotic thrombocytopenic purpura in autoimmune hepatitis. ( Endoh, H; Kuwao, S; Nagaba, S; Saigenji, K; Satomich, A; Shibuya, A, 2001) |
| "Acute idiopathic thrombocytopenic purpura (AITP) in children is generally a benign disease with a high frequency of spontaneous remission." | 1.30 | Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases. ( Baronci, C; Caniglia, M; Caruso, R; De Rossi, G; Lombardi, A; Luciani, M; Miano, C; Petrone, A; Pinto, RM; Rana, I; Russo, LA, 1998) |
| "However, thrombocytopenia is rare and immune thrombocytopenic purpura (ITP) is mentioned only in few case reports." | 1.29 | Tuberculosis presenting as immune thrombocytopenic purpura. ( al-Kassimi, FA; al-Majed, SA; al-Momen, AK; al-Zeer, A; Baaqil, H; Kambal, AM, 1995) |
| "Twenty-six had idiopathic thrombocytopenic purpura (ITP), gave birth to 33 infants, of which 22 were by spontaneous vaginal delivery, eight by lower segment cesarean section, and two by forceps." | 1.29 | Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. ( al Herbish, AS; al-Mobaireek, K; al-Mofada, SM; al-Momen, AK; Kides, E; Osman, ME, 1994) |
| "Chronic idiopathic thrombocytopenic purpura is a destructive thrombocytopenia caused by an autoantibody." | 1.29 | Combination chemotherapy in refractory immune thrombocytopenic purpura. ( Figueroa, M; Gehlsen, J; Hammond, D; McMillan, R; Ondreyco, S; Piro, L; Pomeroy, T; Williams, F, 1993) |
| "Severe autoimmune thrombocytopenic purpura was diagnosed in a 22-year-old woman, gravida 2, para 1, at 28 weeks' gestation." | 1.29 | Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report. ( Gross, Z; Rodriguez, JJ; Stalnaker, BL, 1995) |
| "A young patient developed chronic idiopathic thrombocytopenic purpura." | 1.28 | Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. ( Balduini, CL; Bellotti, V; Bertolino, G; Mazzini, G; Noris, P; Piovella, F; Samaden, A; Sinigaglia, F; Torti, M, 1992) |
| " Newly diagnosed patients with ITP received the usual prednisone therapy, 1 mg/kg/day, for 3 weeks, after which period the dosage was tapered off." | 1.28 | Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP). ( Dubbeld, P; Hillen, HF; van der Heul, C, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (5.47) | 18.7374 |
| 1990's | 49 (24.38) | 18.2507 |
| 2000's | 73 (36.32) | 29.6817 |
| 2010's | 58 (28.86) | 24.3611 |
| 2020's | 10 (4.98) | 2.80 |
| Authors | Studies |
|---|---|
| Lebowa, W | 1 |
| Zdziarska, J | 1 |
| Sacha, T | 1 |
| Skopec, B | 1 |
| Bussel, JB | 2 |
| Ratajczak-Enselme, M | 1 |
| Mutoni, GC | 1 |
| Desmeules, J | 1 |
| Favet, L | 1 |
| Ing Lorenzini, K | 1 |
| Yan, X | 1 |
| Zhang, Y | 2 |
| Lang, H | 1 |
| Huang, Z | 1 |
| Chen, X | 2 |
| He, H | 1 |
| Zhao, Q | 1 |
| Wang, J | 1 |
| Hou, YQ | 1 |
| Wang, Y | 3 |
| Liu, CX | 1 |
| Li, SX | 1 |
| Peng, YL | 1 |
| Dong-Dong, W | 1 |
| Sa, RL | 1 |
| Su, J | 2 |
| Xu, M | 1 |
| Dong, Z | 1 |
| Wang, Q | 1 |
| Ma, L | 1 |
| Xiao, P | 1 |
| Oka, S | 1 |
| Ono, K | 1 |
| Nohgawa, M | 1 |
| Huang, QS | 1 |
| Zhu, XL | 1 |
| Qu, QY | 1 |
| Liu, X | 1 |
| Zhang, GC | 1 |
| Su, Y | 1 |
| Chen, Q | 1 |
| Liu, FQ | 1 |
| Sun, XY | 1 |
| Liang, MY | 3 |
| Liu, Y | 1 |
| Jiang, M | 1 |
| Liu, H | 2 |
| Feng, R | 1 |
| Yao, HX | 1 |
| Zhang, L | 2 |
| Qian, SX | 1 |
| Yang, TH | 1 |
| Zhang, JY | 1 |
| Shen, XL | 1 |
| Yang, LH | 1 |
| Hu, JD | 1 |
| Huang, RW | 1 |
| Jiang, ZX | 1 |
| Wang, JW | 1 |
| Zhang, HY | 1 |
| Xiao, Z | 1 |
| Zhan, SY | 1 |
| Liu, HX | 1 |
| Chang, YJ | 1 |
| Jiang, Q | 1 |
| Jiang, H | 1 |
| Lu, J | 1 |
| Xu, LP | 1 |
| Zhang, XH | 3 |
| Yin, CH | 1 |
| Wang, JL | 2 |
| Huang, XJ | 1 |
| Xu, J | 1 |
| Zhang, X | 1 |
| Feng, S | 1 |
| Zhao, N | 1 |
| Hu, X | 1 |
| Cheng, Y | 2 |
| Wu, Y | 1 |
| Zhou, L | 1 |
| Tong, J | 1 |
| Zheng, C | 1 |
| Patriquin, CJ | 1 |
| Laroche, V | 1 |
| Selby, R | 1 |
| Pendergrast, J | 1 |
| Barth, D | 1 |
| Côté, B | 1 |
| Gagnon, N | 1 |
| Roberge, G | 1 |
| Carrier, M | 1 |
| Castellucci, LA | 1 |
| Scarvelis, D | 1 |
| Mack, JP | 1 |
| Labrosse, R | 1 |
| Vincent, M | 1 |
| Nguyen, UP | 1 |
| Chartrand, C | 1 |
| Di Liddo, L | 1 |
| Pastore, Y | 2 |
| Zhao, X | 1 |
| Qi, X | 1 |
| Wang, C | 1 |
| Zhou, Z | 1 |
| Cao, H | 1 |
| Wu, P | 1 |
| Li, L | 1 |
| Lu, S | 1 |
| Wang, Z | 2 |
| Ergen, EN | 1 |
| Zwerner, JP | 1 |
| Pedini, V | 1 |
| Savore, I | 1 |
| Danieli, MG | 1 |
| Miloudi, M | 1 |
| Sbaai, M | 1 |
| Fatihi, J | 1 |
| Essilini, A | 1 |
| Comont, T | 1 |
| Germain, J | 1 |
| Brun, N | 1 |
| Dingremont, C | 1 |
| Castel, B | 1 |
| Arista, S | 1 |
| Madaule, S | 1 |
| Sailler, L | 2 |
| Lapeyre-Mestre, M | 2 |
| Beyne-Rauzy, O | 1 |
| Godeau, B | 6 |
| Adoue, D | 1 |
| Moulis, G | 2 |
| Xu, X | 1 |
| Dou, S | 1 |
| Simpson, K | 1 |
| Chapman, P | 1 |
| Klag, A | 1 |
| Wei, F | 1 |
| Poston, JN | 1 |
| Gernsheimer, TB | 1 |
| Jin, C | 1 |
| Cheng, H | 1 |
| Liu, T | 1 |
| Ke, B | 1 |
| Li, A | 1 |
| Yang, L | 1 |
| Zhu, Q | 1 |
| Ding, W | 1 |
| Luo, M | 1 |
| Wei, Y | 3 |
| Kong, C | 1 |
| Mithoowani, S | 1 |
| Arnold, DM | 1 |
| Lu, KH | 1 |
| George, JN | 8 |
| Vesely, SK | 4 |
| Terrell, DR | 1 |
| Berrang, T | 1 |
| Holloway, C | 1 |
| Hart, J | 1 |
| Yee, A | 1 |
| Berry, B | 1 |
| Kotb, R | 1 |
| Sakamoto, K | 1 |
| Nakasone, H | 1 |
| Tsurumi, S | 1 |
| Sasaki, K | 1 |
| Mitani, K | 1 |
| Kida, M | 1 |
| Hangaishi, A | 1 |
| Usuki, K | 1 |
| Kobayashi, A | 1 |
| Sato, K | 2 |
| Karasawa-Yamaguchi, M | 1 |
| Izutsu, K | 1 |
| Okoshi, Y | 1 |
| Chiba, S | 1 |
| Kanda, Y | 1 |
| Piccin, A | 1 |
| Amaddii, G | 1 |
| Natolino, F | 1 |
| Billio, A | 1 |
| Cortelazzo, S | 1 |
| van der Lugt, NM | 1 |
| van Kampen, A | 1 |
| Walther, FJ | 1 |
| Brand, A | 1 |
| Lopriore, E | 1 |
| Grainger, JD | 1 |
| Young, NL | 1 |
| Blanchette, VS | 4 |
| Klaassen, RJ | 1 |
| Contis, A | 1 |
| Lazaro, E | 1 |
| Greib, C | 1 |
| Pellegrin, JL | 1 |
| Viallard, JF | 1 |
| Li, J | 1 |
| Dai, L | 1 |
| Cao, L | 1 |
| Zhu, M | 1 |
| Yu, Z | 1 |
| Bai, X | 1 |
| Ruan, C | 2 |
| Lebano, R | 1 |
| Rosato, V | 1 |
| Masarone, M | 1 |
| Romano, M | 1 |
| Persico, M | 1 |
| Hill, LJ | 1 |
| Tung, EE | 1 |
| Langerbeins, P | 1 |
| Busch, R | 1 |
| Anheier, N | 1 |
| Dürig, J | 1 |
| Bergmann, M | 1 |
| Goebeler, ME | 1 |
| Hurtz, HJ | 1 |
| Stauch, MB | 1 |
| Stilgenbauer, S | 1 |
| Döhner, H | 1 |
| Fink, AM | 1 |
| Cramer, P | 1 |
| Fischer, K | 1 |
| Wendtner, CM | 1 |
| Hallek, M | 1 |
| Eichhorst, B | 1 |
| Din, B | 1 |
| Wang, X | 2 |
| Shi, Y | 2 |
| Li, Y | 1 |
| Benadiba, J | 1 |
| Robitaille, N | 1 |
| Lambert, G | 1 |
| Itaj, NK | 1 |
| Uğur Bilgin, A | 1 |
| Karaselek, MA | 1 |
| Bilgin, R | 1 |
| Kuramitsu, K | 1 |
| Fukumoto, T | 1 |
| Yano, Y | 1 |
| Hirano, H | 1 |
| Misumi, T | 1 |
| Katayama, Y | 1 |
| Kawano, H | 1 |
| Yakushijin, K | 1 |
| Zen, Y | 1 |
| Itoh, T | 1 |
| Ku, Y | 1 |
| Ji, XB | 1 |
| Wang, YW | 1 |
| Wang, JX | 1 |
| Yang, EQ | 1 |
| Wang, ZC | 1 |
| Sang, YQ | 1 |
| Bi, ZM | 1 |
| Ren, CA | 1 |
| Zhou, F | 1 |
| Liu, GQ | 1 |
| Peng, J | 2 |
| Hou, M | 5 |
| Palmaro, A | 1 |
| Connell, NT | 1 |
| Berliner, N | 1 |
| Liu, ZH | 1 |
| Zhu, J | 1 |
| Dai, YQ | 1 |
| Shen, H | 1 |
| Ureshino, H | 1 |
| Miyahara, M | 1 |
| Gao, W | 1 |
| Song, JL | 1 |
| Yang, J | 1 |
| Yang, JY | 1 |
| Yan, LN | 1 |
| Matschke, J | 1 |
| Müller-Beissenhirtz, H | 1 |
| Novotny, J | 1 |
| Vester, I | 1 |
| Hertenstein, B | 1 |
| Eisele, L | 1 |
| Lax, H | 1 |
| Ose, C | 1 |
| Dührsen, U | 1 |
| Yin, Y | 1 |
| Deng, M | 1 |
| Peng, H | 1 |
| Zhang, G | 1 |
| Simpson, JD | 1 |
| Matthews, GV | 1 |
| Brighton, TA | 1 |
| Joseph, JE | 1 |
| López-Karpovitch, X | 1 |
| Graue, G | 1 |
| Crespo-Solís, E | 1 |
| Piedras, J | 1 |
| Houwerzijl, EJ | 2 |
| Louwes, H | 2 |
| Sluiter, WJ | 1 |
| Smit, JW | 1 |
| Vellenga, E | 2 |
| de Wolf, JT | 2 |
| Weigert, O | 1 |
| Wittmann, G | 1 |
| Gruetzner, S | 1 |
| Cnossen, J | 1 |
| Becker, MC | 1 |
| Dreyling, M | 1 |
| Ostermann, H | 1 |
| Azar, M | 1 |
| Frates, A | 1 |
| Rajput, V | 1 |
| Yildiz, N | 1 |
| Ardic, F | 1 |
| Deniz, S | 1 |
| Pollock, T | 1 |
| Laliberté, I | 1 |
| Wu, J | 1 |
| Lyons, C | 1 |
| Varghese, L | 1 |
| Viswabandya, A | 1 |
| Mathew, AJ | 1 |
| Iesato, K | 1 |
| Hatakeyama, N | 1 |
| Yamamoto, M | 1 |
| Hori, T | 1 |
| Inazawa, N | 1 |
| Tsutsumi, H | 1 |
| Suzuki, N | 1 |
| Raynard Ortiz, M | 1 |
| Jamart, V | 1 |
| Cambray, C | 1 |
| Borras, R | 1 |
| Mailan, J | 1 |
| Delvecchio, M | 1 |
| De Bellis, A | 1 |
| De Mattia, D | 1 |
| Cavallo, L | 1 |
| Martire, B | 1 |
| Dang, S | 1 |
| Atiq, M | 1 |
| Julka, R | 1 |
| Olden, KW | 1 |
| Aduli, F | 1 |
| Li, CX | 1 |
| Liu, DJ | 1 |
| Pan, CQ | 1 |
| Sang, XF | 1 |
| Li, X | 1 |
| Allegra, A | 1 |
| Penna, G | 1 |
| Alonci, A | 1 |
| Granata, A | 1 |
| D'Angelo, A | 1 |
| Musolino, C | 1 |
| Memon, S | 1 |
| Laing, AD | 1 |
| Frye, JN | 1 |
| Jaso, R | 1 |
| Sierra, M | 1 |
| Calleja, J | 1 |
| Valero, C | 1 |
| Pascual, J | 1 |
| Bowen, DA | 1 |
| Call, TG | 1 |
| Shanafelt, TD | 1 |
| Kay, NE | 1 |
| Schwager, SM | 1 |
| Reinalda, MS | 1 |
| Rabe, KG | 1 |
| Slager, SL | 1 |
| Zent, CS | 1 |
| McDonald, EJ | 1 |
| Butler, A | 1 |
| Sidi, R | 1 |
| Rodak, R | 1 |
| Stüssi, G | 1 |
| Merriman, E | 1 |
| Nandurkar, D | 1 |
| Opat, S | 1 |
| Tran, H | 1 |
| Wang, DP | 1 |
| Wang, SM | 1 |
| Colović, M | 1 |
| Suvajdzic, N | 1 |
| Colović, N | 1 |
| Tomin, D | 1 |
| Vidović, A | 1 |
| Palibrk, V | 1 |
| Li, Z | 1 |
| Mou, W | 1 |
| Lu, G | 1 |
| Cao, J | 1 |
| He, X | 1 |
| Pan, X | 1 |
| Xu, K | 1 |
| Guo, L | 1 |
| Ma, DX | 1 |
| Changela, A | 1 |
| Jagarlamudi, K | 1 |
| Villani, G | 1 |
| Alhuwalia, M | 1 |
| Elnawawi, A | 1 |
| Cui, ZG | 1 |
| Zhao, HG | 1 |
| Wang, HY | 1 |
| Uchiyama, M | 1 |
| Ikeda, T | 1 |
| Mahévas, M | 1 |
| Chiche, L | 1 |
| Uzunhan, Y | 1 |
| Khellaf, M | 1 |
| Morin, AS | 1 |
| Le Guenno, G | 1 |
| Péronne, V | 1 |
| Affo, L | 1 |
| Lidove, O | 1 |
| Boutboul, D | 1 |
| Dion, G | 1 |
| Ducroix, JP | 1 |
| Papo, T | 2 |
| Pacheco, Y | 1 |
| Schleinitz, N | 1 |
| Michel, M | 1 |
| Valeyre, D | 1 |
| Vitale, J | 1 |
| Carbone, F | 1 |
| Stiefelhagen, P | 1 |
| Zeng, Q | 1 |
| Zhu, L | 1 |
| Tao, L | 1 |
| Bao, J | 1 |
| Yang, M | 1 |
| Simpson, EK | 1 |
| Li, C | 1 |
| van der Wal, DE | 1 |
| Chen, P | 1 |
| Spring, CM | 1 |
| Wang, M | 1 |
| Xia, R | 1 |
| Ni, H | 1 |
| Perera, M | 1 |
| Suarez, A | 1 |
| Luzardo, H | 1 |
| Lopez, J | 1 |
| Molero, T | 1 |
| Child, N | 1 |
| O'Carroll, M | 1 |
| Berkahn, L | 1 |
| Rancea, M | 1 |
| Skoetz, N | 1 |
| Monsef, I | 1 |
| Hübel, K | 1 |
| Engert, A | 1 |
| Bauer, K | 1 |
| Madkaikar, M | 1 |
| Ghosh, K | 1 |
| Jijina, F | 1 |
| Gupta, M | 1 |
| Rajpurkar, M | 1 |
| Mohanty, D | 1 |
| Choueiri, T | 1 |
| Lichtin, AE | 1 |
| Ustun, C | 1 |
| Dainer, P | 1 |
| Hendricks, L | 1 |
| Bruker, CT | 1 |
| Burgess, R | 1 |
| Buchanan, GR | 3 |
| Adix, L | 1 |
| Cohen, AR | 2 |
| Kühne, T | 1 |
| Luo, YG | 1 |
| Liu, YQ | 1 |
| Hu, J | 1 |
| Zhang, C | 1 |
| Qin, P | 1 |
| Zhao, C | 1 |
| Ji, X | 1 |
| Zhang, M | 1 |
| Waheed, F | 1 |
| Naseer, N | 1 |
| Ahmed, T | 1 |
| Nelson, JC | 1 |
| Esparza, SD | 1 |
| Moore, TB | 1 |
| Feig, SA | 2 |
| Wong, RS | 1 |
| Soo, YO | 1 |
| Chui, CH | 1 |
| Lau, FY | 1 |
| Chan, NP | 1 |
| Wong, WS | 1 |
| Cheng, G | 1 |
| DAVID, D | 2 |
| CAREDDU, P | 1 |
| DAMESHEK, W | 1 |
| RUBIO, F | 1 |
| MAHONEY, JP | 1 |
| REEVES, WH | 1 |
| BURGIN, LA | 1 |
| LIN, TJ | 1 |
| HALEY, ME | 1 |
| RABINSTEIN, S | 1 |
| GLODT, HR | 1 |
| LAMBETH, SS | 1 |
| MACCHIA, AF | 1 |
| PATZER, F | 1 |
| DU, JN | 1 |
| STAUFFER, MH | 1 |
| LEVIN, M | 1 |
| ROGERS, AG | 1 |
| MALAKHOVSKII, IuE | 1 |
| Raskob, GE | 1 |
| Moore, D | 1 |
| Lyons, RM | 1 |
| Cobos, E | 1 |
| Towell, BL | 1 |
| Klug, P | 1 |
| Guthrie, TH | 1 |
| Owais, Z | 1 |
| Dane, J | 1 |
| Cumming, CG | 1 |
| Chehal, A | 1 |
| Taher, A | 1 |
| Seoud, M | 1 |
| Shamseddine, A | 1 |
| Cooper, N | 1 |
| Heddle, NM | 1 |
| Haas, M | 1 |
| Reid, ME | 1 |
| Lesser, ML | 1 |
| Fleit, HB | 1 |
| Woloski, BM | 1 |
| Lu, XX | 1 |
| Dong, ZQ | 1 |
| Xue, M | 1 |
| Suárez Ortega, S | 1 |
| Campos-Herrero Navas, MI | 1 |
| Limeres González, MA | 1 |
| Díaz López, F | 1 |
| Zarzalejos Andes, JM | 1 |
| Arkuch Saade, ME | 1 |
| Borst, F | 1 |
| Keuning, JJ | 1 |
| van Hulsteijn, H | 1 |
| Sinnige, H | 1 |
| Vreugdenhil, G | 1 |
| Falco, P | 1 |
| Bertola, A | 1 |
| Bringhen, S | 1 |
| Cavallo, F | 1 |
| Boccadoro, M | 1 |
| Palumbo, A | 1 |
| Zhou, YM | 2 |
| Hu, MH | 2 |
| Yang, JM | 1 |
| Zhu, WW | 2 |
| Huang, ZQ | 2 |
| Zhou, SH | 2 |
| Xu, Y | 2 |
| Lu, JH | 2 |
| Price, V | 1 |
| Barnes, C | 1 |
| Canning, P | 1 |
| Blanchette, V | 2 |
| Greenberg, M | 1 |
| Sato, N | 1 |
| Kamata, T | 1 |
| Akiyama, N | 1 |
| Kuwana, M | 1 |
| Kanda, T | 1 |
| Puapong, D | 1 |
| Terasaki, K | 1 |
| Lacerna, M | 1 |
| Applebaum, H | 1 |
| Schulz, C | 1 |
| Kaufmann, R | 1 |
| Ochsendorf, F | 1 |
| Huang, T | 1 |
| Gan, XF | 1 |
| Hamidah, A | 1 |
| Thambidorai, CR | 1 |
| Jamal, R | 1 |
| Zawitkowska-Klaczyńska, J | 1 |
| Nurzyńska-Flak, J | 1 |
| Kattski, K | 1 |
| Kowalczyk, JR | 1 |
| Griffiths, J | 1 |
| Sia, W | 1 |
| Shapiro, AM | 1 |
| Tataryn, I | 1 |
| Turner, AR | 1 |
| Bizzoni, L | 1 |
| Mazzucconi, MG | 2 |
| Gentile, M | 1 |
| Santoro, C | 1 |
| Bernasconi, S | 1 |
| Chiarotti, F | 1 |
| Foà, R | 1 |
| Mandelli, F | 1 |
| O'Brien, SH | 1 |
| Ritchey, AK | 1 |
| Smith, KJ | 1 |
| Konstantinopoulos, PA | 1 |
| Kirby, JE | 1 |
| Miller, KB | 1 |
| Dezube, BJ | 1 |
| Schiff, DE | 1 |
| Roberts, WD | 1 |
| Sue, YJ | 1 |
| Seçkin, H | 1 |
| Kazanci, A | 1 |
| Yigitkanli, K | 1 |
| Simsek, S | 1 |
| Kars, HZ | 1 |
| Jayabose, S | 1 |
| Levendoglu-Tugal, O | 1 |
| Ozkaynak, MF | 1 |
| Sandoval, C | 1 |
| Motamed, F | 1 |
| Zandieh, F | 1 |
| Sedighi, M | 1 |
| García Hernández, FJ | 1 |
| Ocaña Medina, C | 1 |
| González León, R | 1 |
| Garrido Rasco, R | 1 |
| Colorado Bonilla, R | 1 |
| Castillo Palma, MJ | 1 |
| Sánchez Román, J | 1 |
| Rossi, D | 1 |
| De Paoli, L | 1 |
| Franceschetti, S | 1 |
| Capello, D | 1 |
| Vendramin, C | 1 |
| Lunghi, M | 1 |
| Conconi, A | 1 |
| Magnani, C | 1 |
| Gaidano, G | 1 |
| Reale, LD | 1 |
| Besa, EC | 1 |
| Wang, YC | 1 |
| Hu, LQ | 1 |
| Zhang, JS | 1 |
| Vargo, CL | 1 |
| Taylor, SM | 1 |
| Haines, DM | 1 |
| Doganis, D | 1 |
| Baka, M | 1 |
| Pourtsidis, A | 1 |
| Bouhoutsou, D | 1 |
| Varvoutsi, M | 1 |
| Stamos, G | 1 |
| Anastasiou, N | 1 |
| Androulakakis, E | 1 |
| Vasilatou-Kosmidis, H | 1 |
| Zunich, KM | 1 |
| Harkonen, WS | 1 |
| Woloski, M | 1 |
| Kingsbury, L | 1 |
| al-Majed, SA | 1 |
| al-Momen, AK | 2 |
| al-Kassimi, FA | 1 |
| al-Zeer, A | 1 |
| Kambal, AM | 1 |
| Baaqil, H | 1 |
| Llamas, P | 1 |
| Busto, MJ | 1 |
| Díez, JL | 1 |
| Cabrera, R | 1 |
| Regidor, C | 1 |
| Forés, R | 1 |
| Sanjuán, I | 1 |
| Briz, M | 1 |
| Fernández, MN | 1 |
| Weiner, P | 1 |
| Azgad, Y | 1 |
| Weiner, M | 1 |
| Stasi, R | 2 |
| Stipa, E | 2 |
| Masi, M | 2 |
| Cecconi, M | 1 |
| Scimò, MT | 1 |
| Oliva, F | 2 |
| Sciarra, A | 2 |
| Perrotti, AP | 1 |
| Adomo, G | 1 |
| Amadori, S | 1 |
| Tamary, H | 1 |
| Kaplinsky, C | 1 |
| Levy, I | 1 |
| Cohen, IJ | 1 |
| Yaniv, I | 1 |
| Stark, B | 1 |
| Goshen, Y | 1 |
| Zaizov, R | 1 |
| al-Mofada, SM | 1 |
| Osman, ME | 1 |
| Kides, E | 1 |
| al Herbish, AS | 1 |
| al-Mobaireek, K | 1 |
| Barr, RD | 1 |
| Eldor, A | 1 |
| Gillis, S | 1 |
| Ben-Yehuda, D | 1 |
| Bower, W | 1 |
| Coster, D | 1 |
| Wilson, V | 1 |
| Westberg, M | 1 |
| Imbach, P | 1 |
| Andrew, M | 2 |
| Adams, M | 1 |
| McMillan, J | 1 |
| Wang, E | 1 |
| Milner, R | 1 |
| Ali, K | 1 |
| Barnard, D | 2 |
| Bernstein, M | 1 |
| Vermeulen, M | 1 |
| Perrotti, A | 1 |
| Olivieri, M | 1 |
| Zaccari, G | 1 |
| Gandolfo, GM | 2 |
| Galli, M | 1 |
| Dölken, G | 1 |
| Luke, B | 1 |
| Sommerville-Nielsen, S | 1 |
| de Veber, B | 1 |
| Gent, M | 1 |
| Roizin, H | 1 |
| Ballin, A | 1 |
| Hadani, M | 1 |
| Barzilay, Z | 1 |
| Berchtold, P | 1 |
| Wenger, M | 1 |
| Figueroa, M | 1 |
| Gehlsen, J | 1 |
| Hammond, D | 1 |
| Ondreyco, S | 1 |
| Piro, L | 1 |
| Pomeroy, T | 1 |
| Williams, F | 1 |
| McMillan, R | 2 |
| Gross, Z | 1 |
| Rodriguez, JJ | 1 |
| Stalnaker, BL | 1 |
| Medeiros, D | 1 |
| McCaulley, ME | 1 |
| Masłowska, E | 1 |
| Wysocki, M | 1 |
| Michalak-Nowaczyk, A | 1 |
| Anselmi Angeli, R | 1 |
| Ronca, S | 1 |
| Bechini, F | 1 |
| Signorile, PG | 1 |
| Plotti, G | 1 |
| de Alarcon, PA | 1 |
| Gilchrist, GS | 1 |
| Lukens, JN | 1 |
| Moertel, CL | 1 |
| Dickerman, JD | 1 |
| Forman, EN | 1 |
| Glader, BE | 1 |
| Lusher, JM | 1 |
| Lee, WJ | 1 |
| Kim, BR | 1 |
| Zeng, FC | 1 |
| Hong, F | 1 |
| Yang, YQ | 1 |
| Yáñez Maldonado, E | 1 |
| López Rangel, JA | 1 |
| Izquierdo Puente, JC | 1 |
| Jiménez Solís, G | 1 |
| García Alonso López, A | 1 |
| Aggarwal, A | 1 |
| Doolittle, G | 1 |
| Zlatanic, J | 1 |
| Korelitz, BI | 1 |
| Wisch, N | 1 |
| Kim, P | 1 |
| Ammirati, M | 1 |
| Schwarz, S | 1 |
| Gruenstein, S | 1 |
| Lipsey, L | 1 |
| Inoue, Y | 1 |
| Nakagawa, Y | 1 |
| Sawanobori, M | 1 |
| Suzuki, K | 1 |
| Enomoto, H | 1 |
| Carcao, MD | 1 |
| Zipursky, A | 1 |
| Butchart, S | 1 |
| Leaker, M | 1 |
| Böcher, A | 1 |
| Hagmann, FG | 1 |
| Kreiter, H | 1 |
| Arista, MC | 1 |
| Peraino, M | 1 |
| Chistolini, A | 1 |
| Felici, C | 1 |
| Francavilla, V | 1 |
| Macale, E | 1 |
| Conti, L | 1 |
| Baronci, C | 1 |
| Petrone, A | 1 |
| Miano, C | 1 |
| Lombardi, A | 1 |
| Caniglia, M | 1 |
| Russo, LA | 1 |
| Luciani, M | 1 |
| Pinto, RM | 1 |
| Rana, I | 1 |
| Caruso, R | 1 |
| De Rossi, G | 1 |
| Buskard, N | 1 |
| Rock, G | 1 |
| Nair, R | 1 |
| Shekarappa, RJ | 1 |
| Nikolinakos, P | 1 |
| Bansidhar, T | 1 |
| Sistoza, E | 1 |
| Smith, J | 1 |
| Mele, A | 1 |
| Offidani, M | 1 |
| Corvatta, L | 1 |
| Leoni, P | 1 |
| Visser, R | 1 |
| Zweegman, S | 1 |
| Ossenkoppele, GJ | 1 |
| Huijgens, PC | 1 |
| Waintraub, SE | 1 |
| Brody, JI | 1 |
| Lush, R | 1 |
| Iland, H | 1 |
| Peat, B | 1 |
| Young, G | 1 |
| Fabrizio, F | 1 |
| Luzzatto, G | 1 |
| Ramon, R | 1 |
| Randi, ML | 1 |
| De Silvestro, G | 1 |
| Girolami, A | 1 |
| Dickerhoff, R | 1 |
| von Ruecker, A | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Euliano, TY | 1 |
| Zumberg, MS | 1 |
| Frölich, M | 1 |
| Kappers-Klunne, MC | 1 |
| van't Veer, MB | 1 |
| Shibuya, A | 1 |
| Satomich, A | 1 |
| Nagaba, S | 1 |
| Endoh, H | 1 |
| Kuwao, S | 1 |
| Saigenji, K | 1 |
| Funato, K | 1 |
| Kuriyama, Y | 1 |
| Uchida, Y | 1 |
| Suzuki, A | 1 |
| Miyazawa, K | 1 |
| Ohyashiki, K | 1 |
| Chevret, S | 1 |
| Varet, B | 1 |
| Lefrère, F | 1 |
| Zini, JM | 1 |
| Bassompierre, F | 1 |
| Chèze, S | 1 |
| Legouffe, E | 1 |
| Hulin, C | 1 |
| Grange, MJ | 1 |
| Fain, O | 1 |
| Bierling, P | 2 |
| Arnal, C | 1 |
| Piette, JC | 1 |
| Léone, J | 1 |
| Taillan, B | 1 |
| Hachulla, E | 1 |
| Roudot-Thoraval, F | 1 |
| Schaeffer, A | 1 |
| Baron, BW | 1 |
| Martin, MS | 1 |
| Sucharetza, BS | 1 |
| Jeon, H | 1 |
| Baron, JM | 1 |
| Zaja, F | 1 |
| Iacona, I | 1 |
| Masolini, P | 1 |
| Russo, D | 1 |
| Sperotto, A | 1 |
| Prosdocimo, S | 1 |
| Patriarca, F | 1 |
| de Vita, S | 1 |
| Regazzi, M | 1 |
| Baccarani, M | 1 |
| Fanin, R | 1 |
| Mitsuhashi, A | 1 |
| Yamazawa, K | 1 |
| Tanaka, N | 1 |
| Sekiya, S | 1 |
| Ndiaye, O | 1 |
| Sylla, A | 1 |
| Ndiaye, FS | 1 |
| Diagne, I | 1 |
| Diallo-Chauvin, M | 1 |
| Diouf, S | 1 |
| Sallm, G | 1 |
| Kuakuvi, K | 1 |
| Boshkov, LK | 1 |
| Kelton, JG | 1 |
| Halloran, PF | 1 |
| Salat, C | 1 |
| Vehling, U | 1 |
| Böck, M | 1 |
| Gruber, R | 1 |
| Hiller, E | 1 |
| Balduini, CL | 1 |
| Bertolino, G | 1 |
| Noris, P | 1 |
| Piovella, F | 1 |
| Sinigaglia, F | 1 |
| Bellotti, V | 1 |
| Samaden, A | 1 |
| Torti, M | 1 |
| Mazzini, G | 1 |
| Casagranda, I | 1 |
| Davio, P | 1 |
| Moroni, M | 1 |
| Nastasi, G | 1 |
| Porta, C | 1 |
| Kirchner, JT | 1 |
| Dereure, O | 1 |
| Monpoint, S | 1 |
| Donadio, D | 1 |
| Guilhou, JJ | 1 |
| Smith, RE | 1 |
| Gottschall, JL | 1 |
| Pisciotta, AV | 1 |
| Saulsbury, FT | 1 |
| Bringelsen, KA | 1 |
| Dubbeld, P | 1 |
| van der Heul, C | 1 |
| Hillen, HF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sirolimus Treatment for Newly Diagnosed Primary Acquired Pure Red Cell Aplasia: a Single Center Prospective Study[NCT04470804] | Phase 4 | 56 participants (Actual) | Interventional | 2020-07-01 | Completed | ||
| Sirolimus Treatment for Refractory Pure Red Cell Aplasia, a Prospective Study[NCT03364764] | Phase 4 | 64 participants (Actual) | Interventional | 2018-02-01 | Completed | ||
| CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)[NCT00309881] | Phase 2 | 75 participants (Anticipated) | Interventional | 2003-04-30 | Completed | ||
| A Multicenter Prospective Randomized Study of Dexamethasone Combined With Decitabine Versus Dexamethasone in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP)[NCT03252457] | Phase 3 | 200 participants (Anticipated) | Interventional | 2018-09-01 | Not yet recruiting | ||
| Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)[NCT02914054] | Phase 2/Phase 3 | 36 participants (Actual) | Interventional | 2016-10-01 | Completed | ||
| High-dose Dexamethasone and Conventional Dose Prednisone, for the First-line Treatment of Adults With ITP: a Multicenter, Randomized Controlled, Clinical Trial[NCT01356511] | Phase 4 | 261 participants (Actual) | Interventional | 2010-09-30 | Completed | ||
| Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for Adult Patients With Immune Thrombocytopenic Purpura.[NCT01107951] | Phase 2 | 21 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| Cyclophosphamide and Hydroxychloroquine for the Treatment of Severe Thrombocytopenia in Systemic Lupus Erythematosus[NCT02444728] | Phase 3 | 50 participants (Actual) | Interventional | 2015-07-31 | Terminated (stopped due to Because of insufficient enrollement) | ||
| A Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Different Doses of Dexamethasone for Management of Immune Thrombocytopenia (ITP)[NCT02153060] | Phase 2 | 58 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| A Multicentre Investigation of Recombinant Human Thrombopoietin (Rh-TPO) Combine With Low-dose Rituximab in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)[NCT01506414] | Phase 3 | 91 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Recombinant Human Thrombopoietin in Combination With Rituximab Versus Low-dose Rituximab for the Treatment of Refractory ITP.[NCT01525836] | Phase 3 | 123 participants (Actual) | Interventional | 2011-05-31 | Completed | ||
| A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)[NCT01734044] | Phase 3 | 158 participants (Actual) | Interventional | 2012-07-31 | Completed | ||
| A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)[NCT01734057] | Phase 3 | 0 participants (Actual) | Interventional | 2012-07-31 | Withdrawn (stopped due to No eligible patient was enrolled.) | ||
| A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)[NCT00049725] | Phase 2 | 24 participants | Interventional | 2002-11-30 | Completed | ||
| Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | B cells per microliter (Median) |
|---|---|
| Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | Elisa Units (Median) |
|---|---|
| Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
| Intervention | Days (Median) |
|---|---|
| Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
| Intervention | participants (Number) |
|---|---|
| Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
| Intervention | participants (Number) | ||
|---|---|---|---|
| Treatment emergent adverse events | Infusion reactions | Disease Progression | |
| Treated | 0 | 0 | 1 |
21 reviews available for prednisone and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant question.
Topics: Adrenal Cortex Hormones; Adult; Dexamethasone; Female; Humans; Platelet Count; Prednisone; Purpura, | 2023 |
First-Line Therapy for Immune Thrombocytopenia.
Topics: Acute Disease; Adolescent; Adult; Autoimmune Diseases; Blood Platelets; Child; Child, Preschool; Dex | 2019 |
Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.
Topics: Adolescent; Aged; Autoimmune Diseases; Blood Safety; Contraceptives, Oral, Hormonal; Female; Headach | 2015 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
Association of breast cancer and immune thrombocytopenic purpura.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Glucocorticoids; Hu | 2002 |
Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management.
Topics: Adult; Autoimmune Diseases; Combined Modality Therapy; Diagnosis, Differential; Hemorrhage; Humans; | 2004 |
Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura.
Topics: Acute Disease; Aged; Autoantibodies; Gangliosides; Glucocorticoids; Guillain-Barre Syndrome; Humans; | 2005 |
Prolonged remission after splenectomy for refractory Evans syndrome--a case report and literature review.
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Blood Transfusion; Female; Glucocorticoids; Humans; Immun | 2005 |
Chronic subdural hematoma in patients with idiopathic thrombocytopenic purpura: A case report and review of the literature.
Topics: Adolescent; Adult; Aged; Brain; Cerebral Veins; Child; Disease Progression; Female; Glucocorticoids; | 2006 |
Rituximab in autoimmune pancytopenia: a case report and review of literature.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2007 |
Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: review of the literature.
Topics: Adolescent; Amphotericin B; Anemia; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Current controversies in the management of idiopathic thrombocytopenic purpura during childhood.
Topics: Adolescent; Anti-Inflammatory Agents; Cerebral Hemorrhage; Child; Child, Preschool; Female; Humans; | 1996 |
[Autoimmune thrombocytopenia and pregnancy].
Topics: Autoimmune Diseases; Female; Glucocorticoids; Humans; Platelet Count; Prednisone; Pregnancy; Pregnan | 1996 |
[Management of refractory autoimmune thrombocytopenic purpura during pregnancy, Review of the literature and report of three cases].
Topics: Adult; Dexamethasone; Female; gamma-Globulins; Humans; Prednisone; Pregnancy; Pregnancy Complication | 1997 |
Autoimmune thrombocytopenic purpura associated with hyperthyroidism in a single individual.
Topics: Adrenergic beta-Antagonists; Female; gamma-Globulins; Glucocorticoids; Humans; Hyperthyroidism; Inje | 1997 |
Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?
Topics: Adolescent; Adult; Anemia; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Hum | 1997 |
[Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].
Topics: Adult; Autoantibodies; Blood Platelets; Child; Dexamethasone; Diagnosis, Differential; Dose-Response | 1998 |
[Idiopathic thrombocytopenic purpura: diagnostic-therapeutic approach in adults, children and pregnant women].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Cesarean Section; Child; Diagnosis, Differential; Fema | 1999 |
Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Autoimmune Diseases; Blood Platelets; Combined Modality Thera | 2001 |
Initial management of adults with idiopathic (immune) thrombocytopenic purpura.
Topics: Adult; Disease Management; Humans; Isoantibodies; Prednisone; Purpura, Thrombocytopenic, Idiopathic; | 2002 |
Acute and chronic immune thrombocytopenic purpura. Disorders that differ in more than duration.
Topics: Acute Disease; Adult; Blood Component Transfusion; Child; Child, Preschool; Chronic Disease; Female; | 1992 |
29 trials available for prednisone and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Dexamethasone; Female; Helicob | 2014 |
Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cytokines; Drug Therapy, Combination; Female; Follow-Up St | 2013 |
Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cytokines; Drug Therapy, Combination; Female; Follow-Up St | 2013 |
Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cytokines; Drug Therapy, Combination; Female; Follow-Up St | 2013 |
Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cytokines; Drug Therapy, Combination; Female; Follow-Up St | 2013 |
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Long-term effect of high-dose dexamethasone with or without low-dose dexamethasone maintenance in untreated immune thrombocytopenia.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dexamethasone; Female; Humans; Male; Middle Aged | 2015 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Autoantibodies; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up | 2016 |
A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
Topics: Adult; Aged; Dexamethasone; Drug Administration Schedule; Follow-Up Studies; Glucocorticoids; Humans | 2016 |
[Effect of Helicobacter pylori eradication on childhood acute idiopathic thrombocytopenic purpura].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Helic | 2009 |
Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Chronic Disease; Female; Humans; Immunosup | 2011 |
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Dexamethasone; Drug Therap | 2011 |
[The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].
Topics: Adolescent; Adult; Aged; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Male; Midd | 2011 |
[Clinical study on effect of recombinant roasted licorice decoction combined with low-dose glucocorticoids in treating idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Ph | 2001 |
Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.
Topics: Adult; Aged; Autoantibodies; Drug Resistance; Female; Humans; Immunosuppressive Agents; Leukocytes; | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration | 2003 |
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
Topics: Adult; Aged; Disease Management; Female; Glucocorticoids; Hemorrhage; Humans; Isoantibodies; Male; M | 2003 |
[Clinical study on idiopathic thrombocytopenic purpura treated with Shengxueling Granule].
Topics: Adolescent; Adult; Blood Platelets; Child; Drugs, Chinese Herbal; Female; Humans; Immunoglobulins; I | 2004 |
Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow; Female; Glucocorticoids; Hemorrhage; Humans; Immuno | 2005 |
Inspiratory muscle training during treatment with corticosteroids in humans.
Topics: Adrenal Cortex Hormones; Adult; Airway Resistance; Female; Forced Expiratory Volume; Glomerulonephri | 1995 |
Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Age Distribution; Aged; Chronic Disease; Disease-Free Survival; Female; Follow-Up | 1995 |
Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up.
Topics: Child; Chronic Disease; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunoglobulin | 1994 |
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Hemogl | 1994 |
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunog | 1993 |
IVIG, anti-D or oral prednisolone in acute ITP?
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunoglobulins, Intr | 1995 |
[Clinical study of zhinu-I,-II in treating 61 patients with idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Drugs, Chinese Herbal; Female; | 1996 |
Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP).
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Glucocorti | 1998 |
The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group.
Topics: Acute Disease; Albumins; Autoantibodies; Autoimmune Diseases; Canada; Combined Modality Therapy; Fem | 1998 |
Treatment options for chronic idiopathic (immune) thrombocytopenic purpura.
Topics: Drug Administration Schedule; Glucocorticoids; Humans; Prednisone; Purpura, Thrombocytopenic, Idiopa | 2000 |
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Mal | 2002 |
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Danazol; Drug Administration Routes; Dru | 2002 |
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2002 |
151 other studies available for prednisone and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods-One-Center Experience.
Topics: Adult; Hemorrhage; Humans; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Thrombocy | 2023 |
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
Topics: Aged; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Prednisone; Purpura, Thrombocytopen | 2023 |
Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction.
Topics: Animals; Cytokines; Interleukin-10; Interleukin-17; Interleukin-4; Mice; Pituitary Adenylate Cyclase | 2023 |
The association between platelet glycoprotein-specific antibodies and response to short-term high-dose dexamethasone with prednisone maintenance treatment in adult patients with primary immune thrombocytopenia.
Topics: Adult; Autoantibodies; Blood Platelets; Dexamethasone; Humans; P-Selectin; Platelet Glycoprotein GPI | 2022 |
Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.
Topics: Antibodies, Antinuclear; Azathioprine; Humans; Immunosuppressive Agents; Prednisone; Purpura, Thromb | 2023 |
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes.
Topics: Antigens, CD19; B-Lymphocytes; Bone Marrow Cells; CD4-CD8 Ratio; Flow Cytometry; Immunoglobulins, In | 2020 |
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.
Topics: Adult; Area Under Curve; China; Cohort Studies; Disease Susceptibility; Electronic Health Records; F | 2021 |
Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting.
Topics: Adult; Dexamethasone; Humans; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studi | 2021 |
Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Topics: Anticoagulants; ChAdOx1 nCoV-19; Combined Modality Therapy; COVID-19 Vaccines; Female; Fibrin Fibrin | 2021 |
Using a standardised protocol was effective in reducing hospitalisation and treatment use in children with newly diagnosed immune thrombocytopenia.
Topics: Child; Child, Preschool; Clinical Protocols; Female; Hospitalization; Humans; Male; Prednisone; Purp | 2017 |
Idiopathic thrombocytopenic purpura: pathogenesis and potential therapeutic approach.
Topics: Adult; Aged; Animals; Disease Models, Animal; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Ass | 2017 |
Cover image: Intralymphatic histiocytosis with giant blanching violaceous plaques.
Topics: Aged; Drug Therapy, Combination; Exanthema; Histiocytosis; Humans; Immunoglobulins, Intravenous; Mal | 2017 |
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
Topics: Anemia, Hemolytic, Autoimmune; Antigens, Neoplasm; Common Variable Immunodeficiency; Female; Glucoco | 2017 |
Immune thrombocytopenia associated with malaria: a case report.
Topics: Adult; Antimalarials; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Prednisone; Purpura, | 2017 |
Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Blood Coagulation; Female; Humans; Immu | 2018 |
Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy: Response rate and complication.
Topics: Adult; Female; Glucocorticoids; Humans; Hypertension, Pregnancy-Induced; Immunization, Passive; Immu | 2018 |
Long-term outcome of primary immune-mediated thrombocytopenia in dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Prednisone; Purpura, Thrombocyt | 2018 |
Successful treatment of acquired hemophilia A associated with immune thrombocytopenia and joint hemarthrosis: A case report and literature review.
Topics: Adult; Blood Coagulation Factors; Cyclophosphamide; Female; Hemarthrosis; Hemophilia A; Humans; Immu | 2018 |
Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series.
Topics: Adolescent; Adult; Aged; Benzoates; Child, Preschool; Combined Modality Therapy; Drug Synergism; Dru | 2019 |
Platelet and peripheral white blood cell counts at diagnosis predict the response of adult immune thrombocytopenia to recombinant human interleukin-11: A retrospective, single-center, case-control study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Interleukin-11; Leukocyte Count; Mal | 2019 |
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Child; Child, Preschool; Dat | 2014 |
Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2013 |
Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Anticonvulsants; Benzoates; Drug Interactions; Drug R | 2014 |
Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
Topics: Adult; Blood Platelets; Female; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Platelet Coun | 2013 |
Quality of life in immune thrombocytopenia following treatment.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; | 2013 |
Romiplostim as early treatment for refractory primary immune thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Female; Humans; Immunoglobulins, Intravenous; Mal | 2013 |
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Drug Administration Schedule; D | 2014 |
From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia.
Topics: Blood Platelets; Chronic Disease; Female; Glucocorticoids; Helicobacter Infections; Helicobacter pyl | 2014 |
Successful management of refractory immune thrombocytopenia associated with massive alveolar hemorrhage.
Topics: Adult; Benzoates; Factor VIIa; Hemorrhage; Humans; Hydrazines; Immunosuppressive Agents; Male; Plate | 2015 |
A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
Topics: Acute Disease; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; B | 2015 |
Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Dose- | 2015 |
Which 'roid is all the rage?
Topics: Dexamethasone; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Purpura, Thrombocytopenic | 2016 |
Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids.
Topics: Abscess; Antifungal Agents; Child; Drainage; Female; Glucocorticoids; Hair; Humans; Immunocompromise | 2016 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carb | 2016 |
Successful Treatment of Severe Immune Thrombocytopenia After Orthotopic Liver Transplant.
Topics: Adult; Antiviral Agents; Drug Substitution; Drug Therapy, Combination; Humans; Immunoglobulins, Intr | 2018 |
Effects of low-dose thalidomide in chronic refractory immune thrombocytopenia and contributions to the dispensation of glucocorticoid dependence.
Topics: Adult; Chronic Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged | 2016 |
Cytomegalovirus-associated thrombocytopenia treated with thrombopoietin receptor agonist.
Topics: Antiviral Agents; Benzoates; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Hydrazines | 2016 |
High-dose dexamethasone or oral prednisone for immune thrombocytopenia?
Topics: Administration, Oral; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Platelet Co | 2016 |
Multidrug resistance-1 in T lymphocytes and natural killer cells of adults with idiopathic thrombocytopenic purpura: effect of prednisone treatment.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Female; H | 2008 |
Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Platelets; Case-Control Studies; Female; Glucocort | 2008 |
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded platelets.
Topics: Adult; Antineoplastic Agents, Phytogenic; Chronic Disease; Drug Resistance; Female; Glucocorticoids; | 2008 |
Idiopathic thrombocytopenic purpura (ITP) and hyperthyroidism: an unusual but critical association for clinicians.
Topics: Adult; Critical Care; Diagnosis, Differential; Early Diagnosis; Female; Graves Disease; Humans; Pred | 2008 |
Very early onset steroid-induced avascular necrosis of the hip and knee in a patient with idiopathic thrombocytopenic purpura.
Topics: Female; Hip Joint; Humans; Knee Joint; Middle Aged; Osteonecrosis; Prednisone; Purpura, Thrombocytop | 2008 |
Traumatic hyphema and immune thrombocytopenic purpura: late rebleeds associated with low platelet count.
Topics: Anterior Eye Segment; Child, Preschool; Combined Modality Therapy; Dexamethasone; Eye Injuries; Huma | 2008 |
Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy.
Topics: Anti-Inflammatory Agents; Cesarean Section; Danazol; Dapsone; Dexamethasone; Estrogen Antagonists; F | 2008 |
Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Thera | 2009 |
[Anesthetic management in a pregnant woman suffering from idiopathic thrombocytopenic purpura].
Topics: Adult; Anesthesia, Conduction; Anesthesia, Intravenous; Anesthesia, Obstetrical; Blood Loss, Surgica | 2009 |
[Immune thrombocytopenic purpura: pathophysiology and treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Helicobacter pylori; | 2009 |
Growth hormone deficiency and antipituitary antibodies in a patient with common variable immunodeficiency.
Topics: Adolescent; Arthritis, Juvenile; Autoantibodies; Child; Child, Preschool; Common Variable Immunodefi | 2009 |
Isolated gastric mucosal hemorrhages in idiopathic thrombocytopenic purpura.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastroin | 2009 |
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B.
Topics: Adult; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic | 2010 |
Traumatic splenic injury managed with arterial embolisation in a patient with idiopathic thrombocytopenic pupura.
Topics: Adult; Anti-Inflammatory Agents; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeu | 2010 |
Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association?
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Causality; Ele | 2010 |
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2010 |
Immune thrombocytopaenia in adults: a single-centre retrospective review of patients presenting over 7 years.
Topics: Adult; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Azathioprine; Biopsy, Fine-Needle | 2010 |
[Thrombocytopenia].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2010 |
A case of ITP with cauda equina syndrome.
Topics: Anti-Inflammatory Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Polyradiculopathy; | 2011 |
[Clinical analysis of pregnancy complicated with severe thrombocytopenia].
Topics: Adult; Cesarean Section; Erythrocyte Count; Female; gamma-Globulins; Humans; Platelet Count; Platele | 2010 |
[The effects of corticosteroid treatment on immune thrombocytopenia under new diagnostic criteria].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Platelets; Dexamethasone; Female; Glucocorticoids; | 2010 |
Thrombotic thrombocytopenic purpura complicating immune thrombocytopenic purpura--a case report.
Topics: Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Humans; Male; Middle Aged; Plasma | 2011 |
Diffuse large B-cell lymphoma complicated with autoimmune thrombocytopenia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Doxorubicin; Female; | 2011 |
Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Cohort Studies; Comorbidity; Drug Ther | 2011 |
Haemorrhagic herpes zoster.
Topics: Acyclovir; Antiviral Agents; Glucocorticoids; Hemorrhage; Herpes Zoster; Humans; Immunoglobulins, In | 2011 |
[Low thrombocyte count: when does it become dangerous?].
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Contraindications; Dexamethasone; Diagnosis, Di | 2011 |
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Blood Platelets; Dexamethasone; Drug Adm | 2012 |
Spontaneous remission after a year of romiplostim in an adult patient with refractory primary immune thrombocytopenia.
Topics: Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Aspirin; Clopidogrel; Drug Resistance; Hemor | 2012 |
Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; | 2012 |
Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes?
Topics: Aged; Autoimmune Diseases; Bone Marrow; Clone Cells; Diagnosis, Differential; Disease Progression; D | 2002 |
Tuberculosis and immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Aspa | 2002 |
Hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, and chronic lymphocytic leukemia treated with rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001.
Topics: Adult; Child; Female; Hospitalization; Humans; Immunoglobulins, Intravenous; Isoantibodies; Male; Mi | 2003 |
Two patients with heparin-induced thrombocytopenia followed by idiopathic (immune) thrombocytopenic purpura: case report.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Heparin; Humans; Male; Platelet Count; Plate | 2003 |
ITP and empiric steroid treatment.
Topics: Antineoplastic Agents, Hormonal; Bone Marrow Examination; Child; Diagnosis, Differential; Diagnostic | 2003 |
Immune thrombocytopenic purpura--let the treatment fit the patient.
Topics: Adult; Child; Dexamethasone; Glucocorticoids; Humans; Platelet Count; Prednisone; Purpura, Thrombocy | 2003 |
[Amegalokaryocytic idiopathic thrombocytopenic purpura sensitive to prednisone].
Topics: Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Throm | 1956 |
[Amegalokaryocytic idiopathic thrombocytopenic purpura sensitive to prednisone].
Topics: Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Throm | 1956 |
[Amegalokaryocytic idiopathic thrombocytopenic purpura sensitive to prednisone].
Topics: Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Throm | 1956 |
[Amegalokaryocytic idiopathic thrombocytopenic purpura sensitive to prednisone].
Topics: Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Throm | 1956 |
[Clinical & therapeutic aspects of idiopathic thrombocytopenic purpura].
Topics: Child; Cortisone; Humans; Infant; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocy | 1957 |
Treatment of idiopathic thrombocytopenic purpura (ITP) with prednisone.
Topics: Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Throm | 1958 |
Supportive therapy in idiopathic thrombocytopenic purpura with menorrhagia. Report of a case.
Topics: Blood Transfusion; Female; Humans; Menorrhagia; Menstruation; Norethindrone; Prednisone; Purpura; Pu | 1963 |
[Therapeutic efficacy of corticoids in idiopathic thrombocytopenic purpura (ITP) or Werlhof's disease].
Topics: Adrenal Cortex Hormones; Humans; Prednisone; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocyt | 1962 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA AND PREGNANCY: REPORT OF A CASE.
Topics: Adrenocorticotropic Hormone; Cortisone; Female; Humans; Prednisone; Pregnancy; Pregnancy Complicatio | 1964 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA AND PREGNANCY WITH FOLLOW-UP.
Topics: Adrenocorticotropic Hormone; Blood Coagulation Tests; Blood Platelets; Cesarean Section; Drug Therap | 1964 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA: TREATMENT WITH STEROIDS. REPORT OF A CASE.
Topics: Blood Transfusion; Drug Therapy; Humans; Hydrocortisone; Injections; Prednisone; Purpura; Purpura, T | 1964 |
[A CONTRIBUTION TO SPLENECTOMY IN CHRONIC IDIOPATHIC THROMBOPENIA AND IN FELTY'S SYNDROME].
Topics: Adrenocorticotropic Hormone; Drug Therapy; Felty Syndrome; Humans; Prednisone; Purpura; Purpura, Thr | 1964 |
DUBIN-JOHNSON SYNDROME AND IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ONE PATIENT.
Topics: Drug Therapy; Humans; Jaundice; Jaundice, Chronic Idiopathic; Prednisone; Purpura; Purpura, Thromboc | 1965 |
[Prednisone therapy in children with acute and chronic forms of Werlhof's disease].
Topics: Prednisone; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic | 1962 |
Unprovoked periodontal hemorrhage, life-threatening anemia and idiopathic thrombocytopenia purpura: an unusual case report.
Topics: Adult; Aminocaproic Acid; Anemia; Antifibrinolytic Agents; Diagnosis, Differential; Gingival Hemorrh | 2003 |
Idiopathic thrombocytopenic purpura and ovarian cancer.
Topics: Carcinoma, Endometrioid; Diagnosis, Differential; Fallopian Tubes; Female; Humans; Hysterectomy; Mid | 2003 |
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Topics: Adolescent; Adult; Antigens, CD; Blood Platelets; Cytokines; Female; Glucocorticoids; Humans; Immuno | 2004 |
[Treatment of chronic refractory idiopathic thrombocytopenic purpura in children with multiglycosidorum Tripterygii and prednisone].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Human | 2004 |
[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
Topics: Aged; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Aspergillosis; Aspergillus; Auto | 2004 |
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dexamethasone; Dose-Response Relationship, Drug; Fema | 2004 |
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma.
Topics: Antineoplastic Agents; Combined Modality Therapy; Drug Resistance; Humans; Immunoglobulins, Intraven | 2004 |
Immune thrombocytopenia following successful treatment of cancer in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Carmustine; Child, | 2006 |
Splenic artery embolization in the management of an acute immune thrombocytopenic purpura-related intracranial hemorrhage.
Topics: Brain Damage, Chronic; Cerebral Hemorrhage; Child; Coma; Combined Modality Therapy; Embolization, Th | 2005 |
[Generalized purpura as dermatologic manifestation of thrombcytopenia].
Topics: Aged; Biopsy; Bone Marrow; Humans; Male; Megakaryocytes; Platelet Count; Prednisone; Purpura; Purpur | 2006 |
Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunoglobulins; Infant; Male; Prednisone; Purp | 2004 |
Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy.
Topics: Adult; Danazol; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Laparoscopy | 2005 |
Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Disease Progression; Drug Evaluation; Female; Hemorrha | 2006 |
A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
Topics: Acute Disease; Child; Costs and Cost Analysis; Decision Support Techniques; Humans; Immunoglobulins, | 2007 |
Babesiosis masquerading as recurrent immune thrombocytopenic purpura in a splenectomized patient.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Protozoan; Antimalarials; Atovaqu | 2006 |
Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2006 |
Recurrent immune thrombocytopenic purpura in children.
Topics: Adolescent; Adult; Cerebral Hemorrhage; Child; Child, Preschool; Combined Modality Therapy; Female; | 2006 |
Crohn's disease and idiopathic thrombocytopenic purpura in a patient with ectodermal dysplasia and immunodeficiency.
Topics: Anti-Inflammatory Agents; Child, Preschool; Crohn Disease; Ectodermal Dysplasia; Humans; Immunoglobu | 2006 |
[Rituximab for treatment of patients with systemic autoimmune diseases].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyc | 2007 |
Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cohort Studies; Cyclophosphamide; Female; Humans; | 2007 |
[Treatment of idiopathic thrombocytopenic purpura in children: the experience of 92 cases].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunoglobulins, Intravenous; Infant; Infant, N | 2007 |
Immune mediated neutropenia and thrombocytopenia in 3 giant schnauzers.
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Combined Modality Therapy; Dog Diseases; Dogs; Fema | 2007 |
Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura.
Topics: Acute Disease; Anti-Inflammatory Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Iso | 1995 |
Tuberculosis presenting as immune thrombocytopenic purpura.
Topics: Adult; Aged; Antitubercular Agents; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Male | 1995 |
[Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Topics: Adolescent; Adult; Autoimmune Diseases; Combined Modality Therapy; Evaluation Studies as Topic; Fema | 1995 |
Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia.
Topics: Delivery, Obstetric; Female; Humans; Infant, Newborn; Platelet Count; Prednisolone; Prednisone; Preg | 1994 |
Response to "Treatment of childhood chronic ITP".
Topics: Child; Dose-Response Relationship, Drug; Humans; Prednisone; Purpura, Thrombocytopenic, Idiopathic | 1995 |
The response to treatment in chronic idiopathic thrombocytopenic purpura (ITP).
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Chronic Disease; H | 1993 |
Laparoscopic splenectomy.
Topics: Adult; Female; Humans; Laparoscopy; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; | 1995 |
Treatment of childhood immune thrombocytopenic purpura.
Topics: Administration, Oral; Cerebral Hemorrhage; Child; Humans; Immunoglobulins, Intravenous; Platelet Cou | 1994 |
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Antibodies, Antiphospholipi | 1994 |
[What are the therapeutic possibilities in autoimmune thrombocytopenia?].
Topics: Adult; Autoimmune Diseases; Blood Platelets; Humans; Immunosuppressive Agents; Platelet Count; Predn | 1994 |
Intracerebral hemorrhage in an infant with idiopathic thrombocytopenic purpura: approach to the surgical management.
Topics: Cerebral Hemorrhage; Craniotomy; Emergencies; Female; Humans; Immunoglobulins, Intravenous; Infant; | 1993 |
Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Humans; Immunoglobulins, Intravenous; Middle Aged; P | 1993 |
Combination chemotherapy in refractory immune thrombocytopenic purpura.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Hu | 1993 |
Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report.
Topics: Adult; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Female; Glucocorticoids; Humans; Im | 1995 |
Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Ther | 1996 |
[Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Pla | 1996 |
Acute idiopathic thrombocytopenic purpura--management in childhood.
Topics: Adrenal Cortex Hormones; Bone Marrow Examination; Child; Contraindications; Humans; Immunoglobulins, | 1997 |
Laparoscopic splenectomy for chronic idiopathic thrombocytopenic purpura.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Elective Surgical Procedures; Female; Follow-Up St | 1997 |
[Combination chemotherapy (CVP) in a patient with refractory idiopathic thrombocytopenic purpura (ITP)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Female; | 1998 |
Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy.
Topics: Adolescent; Adult; Blood Platelets; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immuno | 1999 |
Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases.
Topics: Acute Disease; Child; Child, Preschool; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenou | 1998 |
Photo quiz. Back rash.
Topics: Acne Vulgaris; Adult; Back; Exanthema; Glucocorticoids; Humans; Male; Prednisone; Purpura, Thrombocy | 1999 |
[Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; | 1999 |
Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Hospitals, Universi | 2000 |
Successful use of dapsone in refractory pregnancy-associated idiopathic thrombocytopenic purpura.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Glucocorticoids; Humans; Immunoglob | 2000 |
Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
Topics: Adrenal Cortex Hormones; Aged; Combined Modality Therapy; Danazol; Extracorporeal Circulation; Femal | 2000 |
The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Immunoglobulins | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.
Topics: Colchicine; Cyclophosphamide; Danazol; Drug Therapy, Combination; Fatal Outcome; Follow-Up Studies; | 2001 |
Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura.
Topics: Adult; Anti-Inflammatory Agents; Cesarean Section; Female; Humans; Platelet Count; Prednisone; Pregn | 2001 |
Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy.
Topics: Adult; Aged; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Headache; H | 2001 |
Thrombotic thrombocytopenic purpura in autoimmune hepatitis.
Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Fatal Outcome; Female; Hepatitis, Autoimmu | 2001 |
Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders.
Topics: Addison Disease; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; B | 2001 |
Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
Topics: Adult; Blood Platelets; Female; Glucocorticoids; Hematopoiesis; Humans; Indium Radioisotopes; Kineti | 2001 |
Autoimmune thrombocytopenia in women with carcinoma of the uterine cervix developing after cisplatin and radiation therapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2002 |
[Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Autoimmune Diseases; Blood Transfusion; Chi | 1999 |
HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura.
Topics: Blood Platelets; Child, Preschool; HLA-DR Antigens; Humans; Interferon-gamma; Leukemia, Erythroblast | 1992 |
[18-year-old patient with petechial hemorrhage].
Topics: Adolescent; Danazol; Hemorrhagic Disorders; Humans; Male; Platelet Count; Prednisone; Purpura; Purpu | 1992 |
Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa.
Topics: Adult; Autoantibodies; Azathioprine; Blood Platelet Disorders; Female; Humans; Platelet Adhesiveness | 1992 |
[The infusion of high-dose immunoglobulins in a case of idiopathic thrombocytopenic purpura].
Topics: Adolescent; Bone Marrow; Humans; Immunoglobulins, Intravenous; Male; Platelet Count; Prednisone; Pur | 1992 |
[Vitiligo associated with autoimmune thrombocytopenia].
Topics: Adult; Humans; Male; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Vitiligo | 1992 |
Life-threatening reaction to staphylococcal protein A immunomodulation.
Topics: Adult; Autoimmune Diseases; Chromatography, Affinity; Female; Fever; Humans; Hypotension; Immunosorb | 1992 |
Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
Topics: Adult; Combined Modality Therapy; Danazol; Humans; Immunoglobulins, Intravenous; Male; Platelet Coun | 1991 |
Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Topics: Adolescent; Adult; Aged; Clinical Protocols; Dexamethasone; Drug Resistance; Female; Follow-Up Studi | 1991 |